Cho HJ - Search Results

1

Mutation-derived Neoantigen-specific T-cell Responses in Multiple Myeloma.

Perumal D, Imai N, Laganà A, Finnigan J, Melnekoff D, Leshchenko VV, Solovyov A, Madduri D, Chari A, Cho HJ, Dudley JT, Brody JD, Jagannath S, Greenbaum B, Gnjatic S, Bhardwaj N, Parekh S. Perumal D, et al. Among authors: cho hj. Clin Cancer Res. 2020 Jan 15;26(2):450-464. doi: 10.1158/1078-0432.CCR-19-2309. Epub 2019 Dec 19. Clin Cancer Res. 2020. PMID: 31857430 Free PMC article.

2

Against the self: dendritic cells versus cancer.

Cho HJ, Bhardwaj N. Cho HJ, et al. APMIS. 2003 Jul-Aug;111(7-8):805-17. doi: 10.1034/j.1600-0463.2003.11107812.x. APMIS. 2003. PMID: 12974782 Review.

3

The cancer-testis antigens CT7 (MAGE-C1) and MAGE-A3/6 are commonly expressed in multiple myeloma and correlate with plasma-cell proliferation.

Jungbluth AA, Ely S, DiLiberto M, Niesvizky R, Williamson B, Frosina D, Chen YT, Bhardwaj N, Chen-Kiang S, Old LJ, Cho HJ. Jungbluth AA, et al. Among authors: cho hj. Blood. 2005 Jul 1;106(1):167-74. doi: 10.1182/blood-2004-12-4931. Epub 2005 Mar 10. Blood. 2005. PMID: 15761016 Free article.

4

Physical interaction of two cancer-testis antigens, MAGE-C1 (CT7) and NY-ESO-1 (CT6).

Cho HJ, Caballero OL, Gnjatic S, Andrade VC, Colleoni GW, Vettore AL, Outtz HH, Fortunato S, Altorki N, Ferrera CA, Chua R, Jungbluth AA, Chen YT, Old LJ, Simpson AJ. Cho HJ, et al. Cancer Immun. 2006 Dec 1;6:12. Cancer Immun. 2006. PMID: 17137291

5

Cellular immune responses against CT7 (MAGE-C1) and humoral responses against other cancer-testis antigens in multiple myeloma patients.

Lendvai N, Gnjatic S, Ritter E, Mangone M, Austin W, Reyner K, Jayabalan D, Niesvizky R, Jagannath S, Bhardwaj N, Chen-Kiang S, Old LJ, Cho HJ. Lendvai N, et al. Among authors: cho hj. Cancer Immun. 2010 Jan 29;10:4. Cancer Immun. 2010. PMID: 20108890 Free PMC article.

6

MAGE-A inhibits apoptosis in proliferating myeloma cells through repression of Bax and maintenance of survivin.

Nardiello T, Jungbluth AA, Mei A, Diliberto M, Huang X, Dabrowski A, Andrade VC, Wasserstrum R, Ely S, Niesvizky R, Pearse R, Coleman M, Jayabalan DS, Bhardwaj N, Old LJ, Chen-Kiang S, Cho HJ. Nardiello T, et al. Among authors: cho hj. Clin Cancer Res. 2011 Jul 1;17(13):4309-19. doi: 10.1158/1078-0432.CCR-10-1820. Epub 2011 May 12. Clin Cancer Res. 2011. PMID: 21565982 Free PMC article.

7

Combination strategies to enhance antitumor ADCC.

Kohrt HE, Houot R, Marabelle A, Cho HJ, Osman K, Goldstein M, Levy R, Brody J. Kohrt HE, et al. Among authors: cho hj. Immunotherapy. 2012 May;4(5):511-27. doi: 10.2217/imt.12.38. Immunotherapy. 2012. PMID: 22642334 Free PMC article. Review.

8

Patients with newly diagnosed multiple myeloma and chromosome 1 amplification have poor outcomes despite the use of novel triplet regimens.

Biran N, Malhotra J, Bagiella E, Cho HJ, Jagannath S, Chari A. Biran N, et al. Among authors: cho hj. Am J Hematol. 2014 Jun;89(6):616-20. doi: 10.1002/ajh.23705. Epub 2014 Apr 30. Am J Hematol. 2014. PMID: 24616227 Free article.

9

Beyond consolidation: auto-SCT and immunotherapy for plasma cell myeloma.

Lendvai N, Cohen AD, Cho HJ. Lendvai N, et al. Among authors: cho hj. Bone Marrow Transplant. 2015 Jun;50(6):770-80. doi: 10.1038/bmt.2015.5. Epub 2015 Mar 9. Bone Marrow Transplant. 2015. PMID: 25751647 Review.

10

Immunotherapy for Multiple Myeloma, Past, Present, and Future: Monoclonal Antibodies, Vaccines, and Cellular Therapies.

Karp Leaf R, Cho HJ, Avigan D. Karp Leaf R, et al. Among authors: cho hj. Curr Hematol Malig Rep. 2015 Dec;10(4):395-404. doi: 10.1007/s11899-015-0283-0. Curr Hematol Malig Rep. 2015. PMID: 26338470 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,883 results

Search Page